EFFICACY AND SAFETY OF RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION IN PATIENTS WITH SEVERE RENAL IMPAIRMENT

被引：0
|
作者：
Ali, S. [1 ]
Wakefield, L. A. [1 ]
Saja, K. [1 ]
机构：
[1] Natl Hlth Serv, London, England
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P409
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [1] The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation
    Shimokawa, Hiroaki
    Yamashita, Takeshi
    Uchiyama, Shinichiro
    Kitazono, Takanari
    Shimizu, Wataru
    Ikeda, Takanori
    Kamouchi, Masahiro
    Kaikita, Koichi
    Fukuda, Koji
    Origasa, Hideki
    Sakuma, Ichiro
    Saku, Keijiro
    Okumura, Yasuo
    Nakamura, Yuichiro
    Morimoto, Hideo
    Matsumoto, Naoki
    Tsuchida, Akihito
    Ako, Junya
    Sugishita, Nobuyoshi
    Shimizu, Shogo
    Atarashi, Hirotsugu
    Inoue, Hiroshi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 258 : 126 - 132
  • [2] The Efficacy and Safety of Oral Rivaroxaban in Patients with Non-Valvular Atrial Fibrillation Scheduled for Electrical Cardioversion
    Enomoto, Yoshinari
    Ito, Naoshi
    Fujino, Tadashi
    Noro, Mahito
    Ikeda, Takanori
    Sugi, Kaoru
    INTERNAL MEDICINE, 2016, 55 (15) : 1953 - 1958
  • [3] Safety and Efficacy of Adjusted Dose of Rivaroxaban in Japanese Patients With Non-Valvular Atrial Fibrillation - Subanalysis of J-ROCKET AF for Patients With Moderate Renal Impairment
    Hori, Masatsugu
    Matsumoto, Masayasu
    Tanahashi, Norio
    Momomura, Shin-ichi
    Uchiyama, Shinichiro
    Goto, Shinya
    Izumi, Tohru
    Koretsune, Yukihiro
    Kajikawa, Mariko
    Kato, Masaharu
    Ueda, Hitoshi
    Iwamoto, Kazuya
    Tajiri, Masahiro
    CIRCULATION JOURNAL, 2013, 77 (03) : 632 - 638
  • [4] The efficacy and safety of edoxaban in non-valvular atrial fibrillation
    Szegedi Andrea
    Csanadi Zoltan
    ORVOSI HETILAP, 2018, 159 (12) : 466 - 469
  • [5] Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
    Andersson, Niklas W.
    Svanstrom, Henrik
    Lund, Marie
    Pasternak, Bjorn
    Melbye, Mads
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 113 - 119
  • [6] Network meta-analysis of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation
    Marx, S.
    Diener, H. -C.
    Harenberg, J.
    Lip, G.
    Marder, V.
    Wehling, M.
    Weiss, C.
    EUROPEAN HEART JOURNAL, 2012, 33 : 815 - 815
  • [7] Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment
    Koretsune, Yukihiro
    Yamashita, Takeshi
    Kimura, Tetsuya
    Fukuzawa, Masayuki
    Abe, Kenji
    Yasaka, Masahiro
    CIRCULATION JOURNAL, 2015, 79 (07) : 1486 - U313
  • [8] Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment
    Fox, Keith A. A.
    Piccini, Jonathan P.
    Wojdyla, Daniel
    Becker, Richard C.
    Halperin, Jonathan L.
    Nessel, Christopher C.
    Paolini, John F.
    Hankey, Graeme J.
    Mahaffey, Kenneth W.
    Patel, Manesh R.
    Singer, Daniel E.
    Califf, Robert M.
    EUROPEAN HEART JOURNAL, 2011, 32 (19) : 2387 - 2394
  • [9] RIVAROXABAN IN PREVENTION OF STROKE IN ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Yavelov, I. S.
    KARDIOLOGIYA, 2019, 59 (12) : 4 - 11
  • [10] J-ROCKET AF: the safety and efficacy of rivaroxaban for prevention of stroke in Japanese patients with non-valvular atrial fibrillation
    Hori, M.
    Matsumoto, M.
    Tanahashi, N.
    Momomura, S.
    Uchiyama, S.
    Goto, S.
    Izumi, T.
    Koretsune, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 20 - 20
12345